Although a trend toward decreased risk of ischemic stroke was observed in patients receiving NOACs, the difference did not reach statistical significance (RR, 0.42; 95% CI, 0.17–1.04).
← all excerpts
Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta-analysis of controlled randomized trials.
1
—
—